Ultrasensitive plasma ctDNA KRAS assay for detection, prognosis, and assessment of therapeutic response in patients with unresectable pancreatic ductal adenocarcinoma
Inna Chen*, Victoria M. Raymond, Jennifer A. Geis, Eric A. Collisson, Benny V. Jensen, Kirstine L. Hermann, Mark G. Erlander, Margaret Tempero, Julia S. Johansen
Dive into the research topics of 'Ultrasensitive plasma ctDNA KRAS assay for detection, prognosis, and assessment of therapeutic response in patients with unresectable pancreatic ductal adenocarcinoma'. Together they form a unique fingerprint.